Interferon alpha vaginal (Vitapharm Technology Development)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha vaginal (Vitapharm Technology Development)
Drug Alias Name阴道给药干扰素αInterferon α vaginalInterferon alfa vaginalOpin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsAtrophic VaginitisVirus Diseases
Global Approved IndicationsVirus Diseases
Approved Indications in ChinaVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesVitapharm Technology Development
China Registration ClassN/A

Develop Information

Active CompaniesVitapharm Technology Development
Inactive CompaniesMylan Pharmaceuticals Inc
Active IndicationsVirus Diseases
Inactive IndicationsAtrophic Vaginitis

Other Information

ATC CodeL03AB
Related LinksN/A